NIH-funded research R01 grant

Improving stem cell therapy for brain cancer using 3D printing

Official title: Harnessing Continuous Liquid Interface 3D Printing to Improve Tumor-homing Stem Cell Therapy for Post-surgical Brain Cancer

Funded at Univ of North Carolina Chapel Hill · NIH-11011262 · Data updated 2026-11-12

This study is exploring how to make brain cancer treatment better by using special 3D-printed structures that help deliver healing stem cells right to the tumor site after surgery, aiming to improve recovery for patients with glioblastoma.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startFebruary 1, 2022
Project endJanuary 31, 2027
Funding year2025
Award (this year)$430,654
NIH project number5R01CA269974-04
Project IDNIH-11011262 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients who have undergone surgery for glioblastoma and are at risk of tumor recurrence.

Less likely to help

Patients with other types of brain tumors or those who have not had surgery for glioblastoma may not benefit from this research.

What this research studies

This research focuses on enhancing the effectiveness of tumor-homing neural stem cells in treating glioblastoma, a deadly brain cancer. By utilizing advanced 3D printing techniques, the study aims to create custom-designed scaffolds that improve the delivery and persistence of these stem cells in the brain after surgery. The researchers will evaluate how different scaffold designs affect the stem cells' ability to migrate, release anti-cancer agents, and ultimately kill tumor cells. This innovative approach could lead to more effective treatments for patients recovering from brain cancer surgery.

Why it matters

Potential benefit: If successful, this research could significantly reduce the recurrence of glioblastoma in patients after surgery.

How similar studies have gone: Previous research has shown promise in using 3D printing for medical applications, but this specific approach targeting glioblastoma is relatively novel.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Hingtgen, Shawn — Univ of North Carolina Chapel Hill
  • Study coordinator: Hingtgen, Shawn

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.